Warren Buffett Sold Over $24 Billion Worth of Stock in 2025, but His Recent $14 Billion in Purchases Sends a Clear Message to Investors

Berkshire Hathaway has been a net seller of equities for 12 consecutive quarters, disposing of more than $24 billion through the first nine months of 2025 and accumulating a record $354 billion cash balance as Warren Buffett judges broad U.S. market valuations overstretched (Buffett Indicator ~225%, S&P PE/CAPE near dot‑com peaks). Still, Berkshire selectively deployed roughly $13.4–$14 billion this year — notably about 17.8 million Alphabet shares (~$4bn), the announced $9.7bn acquisition of OxyChem from Occidental and added stakes in Japanese trading houses Mitsubishi and Mitsui — while retaining Occidental preferreds that yield ~8% and a 28% stake in Occidental, signaling a deliberate shift to undervalued industrial assets, high‑cash‑flow tech and international opportunities outside large‑cap U.S. equities.

Analysis

Berkshire Hathaway has been a net seller of equities for 12 consecutive quarters, disposing of more than $24 billion through the first nine months of 2025 and holding a record $354 billion in cash as of end-Q3. Warren Buffett cites elevated market valuations—the Buffett Indicator near ~225% and S&P 500 PE/CAPE metrics close to dot‑com peaks—as the rationale for reduced public-equity exposure.

Despite the net selling, Berkshire deployed roughly $13.4–$14 billion into select opportunities in 2025: about 17.8 million shares of Alphabet (approximately $4 billion), the announced $9.7 billion acquisition of OxyChem from Occidental, and increased stakes in Japanese trading houses Mitsubishi and Mitsui. Berkshire also retained Occidental preferred shares yielding ~8% and maintains a 28% stake in Occidental, signaling preference for assets with secured cash flows or structural value advantages.

The pattern underscores a deliberate strategy to expand the investable universe into high‑free‑cash‑flow tech priced below ~20x forward earnings (Alphabet), undervalued industrials/chemicals achievable via corporate transactions, and comparatively cheaper Japanese equities (Mitsubishi/Mitsui price‑to‑book ~1.5). Investors should note Berkshire’s unique access to private deals and scale constraints—its moves signal where value may exist but do not guarantee easily replicable opportunities for smaller investors.

Key Decisions for Investors

• Reduce relative exposure to richly valued large‑cap U.S. equities and maintain higher cash or hedges given prolonged net selling by Berkshire and stretched market valuation metrics
• Shift a measured portion of risk capital toward selectively undervalued areas Berkshire targeted — high free‑cash‑flow tech trading below ~20x forward, chemicals/industrials where M&A creates value, and Japanese trading houses — sizing positions for liquidity and research capacity
• Evaluate high‑yield alternatives such as preferred securities where credit risk is understood (article cites Occidental preferreds at ~8%), but perform issuer and structural due diligence before allocating
• If you cannot access private deals Berkshire prefers, use active managers, targeted ETFs for Japan/small caps, or concentrated fundamental picks and monitor valuation indicators (Buffett Indicator, PE/CAPE) as entry/exit signals